Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
Sell
-94,500
Closed -$14.1M 10908
2025
Q3
$14.1M Buy
+94,500
New +$13.9M ﹤0.01% 2936
2021
Q3
Sell
-22,500
Closed -$723K 9834
2021
Q2
$723K Hold
22,500
﹤0.01% 4456
2021
Q1
$677K Buy
+22,500
New +$584K ﹤0.01% 4619
2020
Q4
Sell
-80,000
Closed -$2.11M 8586
2020
Q3
$2.11M Buy
+80,000
New +$3.09M ﹤0.01% 2994

Other funds holding LRN

UBS Group's LRN Position: Q2 2026 in Review

UBS Group reduced its Stride (LRN) stake by 11% in Q2 2026, selling an estimated $6.01M and leaving 530,833 shares worth $45.8M. The position accounts for 0.01% of the portfolio, ranked #1833.

UBS Group first reported a position in LRN in Q4 2014 and has held it in 45 quarters since. The position peaked at $144M in Q2 2025. 414 funds tracked by Wall St. Rank hold LRN as of Q2 2026.

  • UBS Group held 530,833 shares of Stride worth $45.8M as of Q2 2026.
  • UBS Group sold 65,354 Stride shares in Q2 2026, an estimated $6.01M.
  • Stride made up 0.01% of UBS Group's portfolio in Q2 2026, its #1833 holding.
  • UBS Group first reported a position in Stride in Q4 2014 and has held it in 45 quarters since.
  • UBS Group's Stride position peaked at $144M in Q2 2025.
  • 414 funds tracked by Wall St. Rank held Stride as of Q2 2026.

Based on UBS Group's 13F filing for Q2 2026, filed 13 Aug 2026.